Arcutis Biotherapeutics
ARQT
24.17
+0.25
+1.05%
Arcutis Biotherapeutics
US · ARQT
#2465 by market cap
Listed 2020
24.17
+0.25
+1.05%
Live - 5344 symbols - heartbeat 247s ago
· 2026-10-08 07:15
Pre-market
24.22
+0.21%
After-hours
24.17
0.00%
- Market cap
- 3.04B
- P/E (TTM)i
- 109.86
- P/Bi
- 13.77
- EPSi
- -0.13
- Div yieldi
- 0.00%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on ARQT?
Anonymous reader poll. Unscientific, not investment advice.
About Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
- Founded
- 2016
- CEO
- Mr. Todd Franklin Watanabe
- Employees
- 354
- Headquarters
- Westlake Village, California, United States of America
- Fiscal year end
- 12-31
- Website
- arcutis.com
Company profile
- Exchange
- US
- Symbol
- ARQT
- Market-cap rank
- #2465
- Listing date
- 2020-01-31
- Market cap
- 3.04B
- Float cap
- 2.27B
- Shares out
- 125.69M
- Float shares
- 93.82M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 07:15:25 · For reference only, not investment advice and not tailored to your situation.